Ulcerative Colitis
Alicaforsen significantly improves symptoms of ulcerative colitis
Published in Drug Week, December 31st, 2004
In these phase II clinical trials, alicaforsen enema produced significant and long-lasting disease improvement, as measured by changes in Disease Activity Index (DAI) scores and other indicators of disease.
In particular, a substantial number of patients treated with alicaforsen enema experienced mucosal healing, as well as decreases in rectal bleeding and in stool frequency; manifestations of the disease that cause considerable discomfort, inconvenience and pain to patients. In all three trials,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2004-12-31)
More Articles from Drug Week
- Addiction Medicine
Isoelectric focusing of transferrin clarifies alcohol abuse markers - Colorectal Cancer
Data show ELOXATIN-based therapy combined with Bevacizumab improves survival - Multiple Myeloma
Aplidin granted orphan drug status by European Commission - Plasmodium Vivax
Cysteine proteases of Plasmodium vivax as drug targets, analyses conducted - ADHD Therapy
Children have greater reduction of symptoms with higher doses of Concerta - Acute Lymphoblastic Leukemia
U.S. FDA committee recommends accelerated clofarabine approval for ALL - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
